Information pursuant to Sect. 5 German Telemedia Act (TMG)

Maximilianstrasse 4e
82319 Starnberg

Commercial Register: HRB 108588
Registration court: Amtsgericht München

Represented by:
Ulrike Däxl, Klaus Manlik


Phone: +49 8151 / 973650
Telefax: +49 8151 / 9736525


Sales tax identification number according to Sect. 27 a of the Sales Tax Law:
DE 170526265

Responsible for the content according to Sect. 55, paragraph 2 RStV

Klaus Manlik
Maximilianstrasse 4e
82319 Starnberg

EU dispute resolution

The European Commission provides a platform for online dispute resolution (ODR):
Our e-mail address can be found above in the site notice.

Dispute resolution proceedings in front of a consumer arbitration board

We are not willing or obliged to participate in dispute resolution proceedings in front of a consumer arbitration board.

Liability for Contents

As service providers, we are liable for own contents of these websites according to Paragraph 7, Sect. 1 German Telemedia Act (TMG). However, according to Paragraphs 8 to 10 German Telemedia Act (TMG), service providers are not obligated to permanently monitor submitted or stored information or to search for evidences that indicate illegal activities.

Legal obligations to removing information or to blocking the use of information remain unchallenged. In this case, liability is only possible at the time of knowledge about a specific violation of law. Illegal contents will be removed immediately at the time we get knowledge of them.

Liability for Links

Our offer includes links to external third party websites. We have no influence on the contents of those websites, therefore we cannot guarantee for those contents. Providers or administrators of linked websites are always responsible for their own contents.

The linked websites had been checked for possible violations of law at the time of the establishment of the link. Illegal contents were not detected at the time of the linking. A permanent monitoring of the contents of linked websites cannot be imposed without reasonable indications that there has been a violation of law. Illegal links will be removed immediately at the time we get knowledge of them.


Contents and compilations published on these websites by the providers are subject to German copyright laws. Reproduction, editing, distribution as well as the use of any kind outside the scope of the copyright law require a written permission of the author or originator. Downloads and copies of these websites are permitted for private use only.
The commercial use of our contents without permission of the originator is prohibited.

Copyright laws of third parties are respected as long as the contents on these websites do not originate from the provider. Contributions of third parties on this site are indicated as such. However, if you notice any violations of copyright law, please inform us. Such contents will be removed immediately.


GDPR Cookie Consent with Real Cookie BannerCovid 19 News inside
Manlik Pharma Consultants begleitete einen komplexen Verkaufsprozess der Schwabe-Gruppe

Spitzner Wellness Markenportfolio wurde in Kombination mit dem Carve-out des Produktionsstandorts Ettlingen veräußert

Manlik Pharma Consultants begleitete Schwabe-Gruppe im Verkaufsprozess des Unternehmens Spitzner in Kombination mit dem Carve-out des Produktionsstandorts EttlingenDie in Starnberg ansässige M&A Beratung für die pharmazeutische Industrie, MANLIK PHARMA CONSULTANTS GMBH, begleitete das Familienunternehmen Dr. Willmar Schwabe GmbH & Co. KG im Verkaufsprozess des Unternehmens Spitzner in Kombination mit dem Carve-Out des Produktionsstandortes Ettlingen an die neu gegründete W. Spitzner Arzneimittelfabrik GmbH.
Neben der Lohnherstellung steht die Weiterentwicklung des traditionell starken Spitzner- Markenportfolios, hauptsächlich bestehend aus Körperpflege- und  Wellness-Produkten im Fokus. Der gesamte Prozess dauerte ein knappes Jahr, das Closing fand Anfang Oktober 2022 statt.
Die zuständige Projektleiterin und Managing Director Ulrike Däxl von MANLIK PHARMA CONSULTANTS GMBH gratuliert dem Kunden: „Hier haben zwei Partner zusammengefunden, die eine professionelle Basis für eine zuverlässige Lohnherstellungskooperation geschaffen haben.“ 

MANLIK PHARMA CONSULTANTS ist eine M&A Boutique, die seit über 30 Jahren M&A Deals (Share Deals und Asset Deals) vorrangig im Auftrag der mittelständischen Pharmaindustrie abwickelt und begleitet und seit 1991 bereits mehr als 600 Transaktionen erfolgreich abgeschlossen hat.